Improving Clinical Practice... One Change at a Time

CME Outfitters podcasts

Novel Treatment of Inflammatory Bowel Disease Informed by Science and Patient Choice 


Inflammatory bowel disease (IBD), which consists of Crohn’s disease (CD) and ulcerative colitis (UC), is a chronic inflammatory disease of the gut, which develops because of an excessive immune response to the normal gut flora in a genetically susceptible host.1 Current therapies for IBD have not, as yet, been able to prevent the need for surgical intervention in more than 50% of IBD patients. Education to clinicians who manage patients with moderate-to-severe IBD about the immunopathophysiology of IBD and the latest available options to individualize IBD treatment can reduce the use of corticosteroids and need for hospitalizations or surgery resulting in improved quality of life for these patients. Clinicians often treat IBD based only on diagnosis rather than considering an individual’s uniqueness, personal history, risk factors, genetics, possible immunopathogenesis, and the natural history of the disease.

Categories | CME Outfitters, LLC


Filetype: MP4 - Size: 273.23MB - Duration: 1:32:07 m